Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients.

Genes (Basel) · 2026 · PMC13116932 · PMID 42074578

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

It has been reported that tumors with stronger immune signature (for example, increased T cells) showed a trend towards increased benefit from treatment with the triplet with binimetinib [ 60 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.